Arcturus Therapeutics to attend Leerink Partners 2026 Global Healthcare Conference

Arcturus Therapeutics to attend Leerink Partners 2026 Global Healthcare Conference
Arcturus joins Leerink healthcare event

Arcturus Therapeutics announced it will attend the upcoming Leerink Partners 2026 Global Healthcare Conference.

The company aims to present its advancements in mRNA therapeutics and rare disease treatment at the event. The conference is considered a major gathering for leaders in the healthcare and biotech sectors. Details regarding presentation schedules and potential partnerships or business developments are expected to be disclosed at the conference.

The upcoming conference appearance builds on Arcturus Therapeutics’ recent momentum in mRNA innovation and business development—a trend underscored by the company’s latest financial reporting and pipeline progress. For a detailed examination of these developments, see the earlier analysis of Arcturus Therapeutics’ financial results and mRNA pipeline updates.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.
Weekly Top Bonuses
up to $2,500
deposit bonus for all clients
CLAIM BONUS
Your capital is at risk.